ArticleThe Journal of clinical investigation2023

FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway.

Yunjiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.